bf/NASDAQ:GENE_icon.jpeg

NASDAQ:GENE

Genetic Technologies Limited

  • Stock

USD

Last Close

2.25

03/05 20:00

Market Cap

7.60M

Beta: 0.53

Volume Today

27.86K

Avg: 482.49K

Jun '13
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
average inventory
265.25K
-
213.39K
19.55%
265.25K
24.30%
242.22K
8.68%
121.88K
49.68%
67.91K
44.28%
45.44K
33.10%
61.63K
35.64%
84.16K
36.56%
237.54K
182.25%
362.02K
52.41%
average payables
763.99K
-
761.25K
0.36%
708.68K
6.91%
454.70K
35.84%
395.31K
13.06%
467.11K
18.16%
563.08K
20.55%
470.19K
16.50%
309.91K
34.09%
711.76K
129.67%
995.90K
39.92%
average receivables
412.31K
-
720.10K
74.65%
913.26K
26.82%
672.86K
26.32%
528.52K
21.45%
363.83K
31.16%
560.07K
53.94%
804.06K
43.56%
931.84K
15.89%
1.75M
87.56%
2.17M
24.24%
book value per share
0.01
-
0.00
73.37%
0.02
455.61%
0.01
60.80%
0.00
28.03%
0.00
58.42%
0.00
65.26%
0.00
366.09%
0.00
19.55%
0.00
29.29%
0.00
32.06%
capex per share
-0.00
-
-0.00
26.56%
-0.00
115.26%
-0.00
1.45%
-0.00
37.45%
-0.00
99.05%
-0.00
1,849.18%
-0.00
51.96%
-0.00
719.43%
-0.00
86.03%
-0.00
82.44%
capex to depreciation
-0.13
-
-0.14
5.19%
-0.83
485.83%
-0.78
6.20%
-0.63
18.78%
-0.01
98.76%
-0.17
-
capex to operating cash flow
0.01
-
0.00
38.85%
0.02
355.66%
0.04
97.63%
0.03
12.26%
0.00
98.77%
0.01
1,852.45%
0.01
19.48%
0.10
1,368.14%
0.01
84.91%
0.00
88.42%
capex to revenue
-0.02
-
-0.01
33.87%
-0.10
811.82%
-0.37
284.45%
-0.45
23.05%
-0.01
97.22%
-1.98
15,589.78%
-3.86
95.35%
-5.33
37.87%
-0.01
99.73%
-0.00
86.26%
cash per share
0.00
-
0.00
20.62%
0.02
246.68%
0.01
61.87%
0.00
20.55%
0.00
53.37%
0.00
63.22%
0.00
312.58%
0.00
28.49%
0.00
47.99%
0.00
33.07%
days of inventory on hand
40.11
-
42.30
5.47%
130.03
207.37%
82.00
36.93%
56.94
30.56%
71.77
26.04%
42.10
41.34%
132.63
215.03%
77.77
41.36%
452.41
481.70%
27.44
93.94%
days payables outstanding
116.74
-
178.81
53.17%
211.76
18.43%
192.71
9.00%
295.23
53.20%
651.85
120.79%
779.80
19.63%
508.15
34.84%
272.63
46.35%
1.31K
380.91%
70.55
94.62%
days sales outstanding
35.52
-
88.89
150.26%
129.71
45.92%
279.21
115.26%
300.07
7.47%
581.25
93.70%
11.75K
1,920.69%
29.21K
148.68%
3.25K
88.86%
130.06
96.00%
80.75
37.91%
debt to assets
0.37
-
0.00
99.68%
0.03
-
0.01
71.18%
0.03
253.17%
0.04
14.34%
debt to equity
1.37
-
0.00
99.90%
0.04
-
0.01
74.40%
0.04
319.11%
0.05
20.20%
dividend yield
earnings yield
-0.21
-
-0.49
132.35%
-0.29
40.09%
-0.26
11.50%
-0.57
118.01%
-0.24
57.52%
-0.40
65.09%
-0.30
23.54%
-0.10
67.29%
-0.26
159.75%
-0.51
97.74%
enterprise value
42.65M
-
20.35M
52.28%
11.72M
42.41%
21.41M
82.64%
3.86M
81.96%
17.24M
346.38%
15.09M
12.50%
7.04M
53.32%
51.93M
637.32%
16.58M
68.07%
15.73M
5.12%
enterprise value over ebitda
-4.56
-
-1.90
58.31%
-1.28
32.60%
-2.54
98.08%
-0.51
79.93%
-2.89
467.89%
-2.52
13.03%
-1.16
53.98%
-7.35
535.08%
-4.47
39.24%
-1.70
61.87%
ev to operating cash flow
-5.67
-
-1.85
67.35%
-1.21
34.71%
-2.77
129.08%
-0.57
79.54%
-3.07
441.07%
-2.48
19.01%
-1.23
50.36%
-7.92
542.41%
-2.53
68.05%
-1.58
37.42%
ev to sales
12.63
-
4.46
64.69%
5.83
30.64%
25.96
345.63%
7.45
71.31%
91.10
1,122.98%
592.90
550.80%
713.98
20.42%
430.74
39.67%
2.44
99.43%
1.81
25.78%
free cash flow per share
-0.01
-
-0.02
19.77%
-0.01
52.03%
-0.00
49.18%
-0.00
29.04%
-0.00
25.52%
-0.00
0.62%
-0.00
40.44%
-0.00
39.13%
-0.00
14.40%
-0.00
49.66%
free cash flow yield
-0.17
-
-0.53
212.74%
-0.33
38.32%
-0.25
25.11%
-0.47
92.61%
-0.25
47.87%
-0.36
43.74%
-0.28
22.18%
-0.10
64.19%
-0.24
142.53%
-0.43
79.59%
graham net net
-0.00
-
-0.00
234.11%
0.02
920.80%
0.01
62.59%
0.00
23.17%
0.00
59.20%
0.00
71.55%
0.00
487.25%
0.00
19.28%
0.00
57.22%
0.00
38.55%
graham number
0.07
-
0.03
51.32%
0.05
60.91%
0.03
51.48%
0.02
23.97%
0.01
49.77%
0.01
36.64%
0.01
65.15%
0.01
33.12%
0.01
19.49%
0.01
5.81%
income quality
0.80
-
1.08
34.85%
1.10
1.47%
0.91
16.96%
0.81
11.24%
1.03
26.89%
0.92
-
intangibles to total assets
0.16
-
0.18
11.56%
0.04
79.72%
0.05
28.89%
0
100%
0
0
0
0
0.25
Infinity%
0.24
0.75%
interest coverage
-233.75
-
-12.54
94.63%
-30.60
143.95%
-292.81
856.95%
-249.89
14.66%
-207.24
17.07%
-299.44
44.49%
-410.45
37.07%
-502.78
22.49%
-282.05
43.90%
-335.95
19.11%
interest debt per share
0.00
-
0.01
6,745.50%
0.00
95.22%
0.00
93.76%
0.00
10.46%
0.00
15.85%
0.00
35.83%
0.00
1,472.52%
0.00
78.64%
0.00
183.73%
0.00
15.78%
inventory turnover
9.10
-
8.63
5.18%
2.81
67.47%
4.45
58.56%
6.41
44.01%
5.09
20.66%
8.67
70.48%
2.75
68.26%
4.69
70.53%
0.81
82.81%
13.30
1,548.85%
invested capital
1.37
-
0.00
99.90%
0.04
-
0.01
74.40%
0.04
319.11%
0.05
20.20%
market cap
44.38M
-
20.68M
53.39%
30.04M
45.23%
32.59M
8.49%
14.85M
54.43%
22.73M
53.05%
17.22M
24.25%
20.78M
20.66%
72.63M
249.58%
27.66M
61.91%
23.05M
16.67%
net current asset value
96.18K
-
-541.17K
662.69%
17.81M
3,390.20%
10.72M
39.77%
10.10M
5.80%
4.54M
55.09%
1.70M
62.49%
12.58M
638.90%
20.80M
65.39%
10.35M
50.25%
6.80M
34.24%
net debt to ebitda
0.18
-
0.03
83.32%
2.00
6,421.97%
1.33
33.80%
1.45
9.33%
0.92
36.47%
0.36
61.38%
2.26
535.08%
2.93
29.83%
2.98
1.84%
0.79
73.46%
net income per share
-0.02
-
-0.02
11.02%
-0.01
53.40%
-0.00
39.95%
-0.00
19.68%
-0.00
39.31%
-0.00
15.56%
-0.00
41.48%
-0.00
44.40%
-0.00
8.32%
-0.00
64.79%
operating cash flow per share
-0.01
-
-0.02
20.10%
-0.01
52.76%
-0.00
50.13%
-0.00
28.71%
-0.00
22.99%
-0.00
0.17%
-0.00
40.34%
-0.00
44.19%
-0.00
7.39%
-0.00
51.61%
payables turnover
3.13
-
2.04
34.71%
1.72
15.56%
1.89
9.89%
1.24
34.72%
0.56
54.71%
0.47
16.41%
0.72
53.46%
1.34
86.39%
0.28
79.21%
5.17
1,758.41%
receivables turnover
10.28
-
4.11
60.04%
2.81
31.47%
1.31
53.55%
1.22
6.95%
0.63
48.38%
0.03
95.05%
0.01
59.79%
0.11
797.98%
2.81
2,400.89%
4.52
61.07%
research and ddevelopement to revenue
1.03
-
0.72
29.52%
1.42
96.15%
3.13
121.15%
4.56
45.59%
11.68
155.93%
92.78
694.37%
251.17
170.71%
25.79
89.73%
0.10
99.60%
0.15
42.05%
return on tangible assets
-1.33
-
-1.82
36.84%
-0.44
75.83%
-0.67
51.30%
-0.69
4.05%
-0.89
27.67%
-2.09
136.18%
-0.40
80.73%
-0.31
22.19%
-0.46
45.03%
-1.05
130.17%
revenue per share
0.01
-
0.01
11.05%
0.00
76.39%
0.00
74.37%
0.00
49.16%
0.00
65.93%
0.00
87.58%
0.00
75.41%
0.00
494.34%
0.00
5,122.98%
0.00
27.83%
roe
-1.66
-
-5.54
234.08%
-0.46
91.61%
-0.71
53.19%
-0.79
11.60%
-1.16
45.97%
-3.86
232.69%
-0.48
87.44%
-0.33
30.89%
-0.43
29.65%
-1.05
142.56%
roic
-1.48
-
-2.03
37.43%
-0.46
77.59%
-0.69
50.66%
-0.76
10.54%
-1.39
83.81%
-3.60
158.25%
-0.45
87.46%
-0.33
27.39%
-0.24
26.53%
-0.80
232.17%
sales general and administrative to revenue
2.02
-
0.93
53.82%
2.32
148.53%
4.28
85.04%
5.66
32.06%
15.94
181.65%
150.53
844.66%
411.45
173.33%
34.49
91.62%
0.32
99.07%
1.04
223.27%
shareholders equity per share
0.01
-
0.00
73.37%
0.02
455.61%
0.01
60.80%
0.00
28.03%
0.00
58.42%
0.00
65.26%
0.00
366.09%
0.00
19.55%
0.00
29.29%
0.00
32.06%
stock based compensation to revenue
0.07
-
0.03
60.34%
0.15
476.07%
0.06
59.61%
0.23
280.77%
0.68
195.27%
tangible asset value
4.45M
-
648.53K
85.43%
18.22M
2,709.94%
11.27M
38.13%
10.58M
6.17%
4.71M
55.46%
1.77M
62.41%
13.02M
634.83%
21.53M
65.44%
11.30M
47.52%
7.53M
33.40%
tangible book value per share
0.01
-
0.00
88.03%
0.02
1,404.91%
0.01
61.30%
0.00
24.14%
0.00
58.42%
0.00
65.26%
0.00
366.09%
0.00
19.55%
0.00
51.37%
0.00
33.40%
working capital
192.40K
-
2.04M
961.59%
17.83M
773.00%
10.80M
39.44%
10.17M
5.86%
4.54M
55.34%
1.70M
62.50%
13.80M
710.20%
20.83M
51.00%
10.91M
47.65%
7.19M
34.11%

All numbers in USD (except ratios and percentages)